Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 71 | 2025 | 1304 | 14.350 |
Why?
|
Endovascular Procedures | 39 | 2024 | 2216 | 6.640 |
Why?
|
Angioplasty, Balloon | 16 | 2024 | 592 | 5.880 |
Why?
|
Femoral Artery | 30 | 2024 | 829 | 5.620 |
Why?
|
Drug-Eluting Stents | 21 | 2023 | 681 | 5.490 |
Why?
|
Pulmonary Embolism | 29 | 2024 | 2599 | 4.920 |
Why?
|
Popliteal Artery | 19 | 2024 | 313 | 3.560 |
Why?
|
Ultrasonography, Interventional | 11 | 2024 | 1523 | 3.420 |
Why?
|
Cardiovascular Agents | 10 | 2024 | 849 | 2.910 |
Why?
|
Paclitaxel | 21 | 2024 | 1728 | 2.590 |
Why?
|
Medicare | 42 | 2025 | 6809 | 2.570 |
Why?
|
Coated Materials, Biocompatible | 13 | 2024 | 311 | 2.120 |
Why?
|
Lower Extremity | 17 | 2024 | 1216 | 2.100 |
Why?
|
Treatment Outcome | 119 | 2025 | 65364 | 2.040 |
Why?
|
Limb Salvage | 17 | 2024 | 488 | 2.010 |
Why?
|
Intermittent Claudication | 10 | 2024 | 305 | 1.870 |
Why?
|
Thrombosis | 10 | 2024 | 2957 | 1.800 |
Why?
|
Ischemia | 16 | 2025 | 1900 | 1.720 |
Why?
|
Coronary Artery Disease | 16 | 2023 | 6569 | 1.650 |
Why?
|
Platelet Aggregation Inhibitors | 18 | 2024 | 2764 | 1.640 |
Why?
|
Vascular Patency | 13 | 2024 | 917 | 1.630 |
Why?
|
Carotid Stenosis | 7 | 2024 | 859 | 1.560 |
Why?
|
Myocardial Infarction | 25 | 2024 | 11519 | 1.530 |
Why?
|
Stents | 20 | 2024 | 3195 | 1.470 |
Why?
|
Registries | 32 | 2024 | 8377 | 1.460 |
Why?
|
Vena Cava Filters | 5 | 2024 | 270 | 1.450 |
Why?
|
Endarterectomy, Carotid | 6 | 2024 | 556 | 1.380 |
Why?
|
Coronary Restenosis | 4 | 2022 | 396 | 1.360 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2024 | 1456 | 1.310 |
Why?
|
Patient Readmission | 12 | 2021 | 3288 | 1.290 |
Why?
|
United States | 79 | 2025 | 73027 | 1.290 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2024 | 707 | 1.290 |
Why?
|
Risk Factors | 89 | 2025 | 74936 | 1.230 |
Why?
|
Venous Thrombosis | 5 | 2024 | 1323 | 1.220 |
Why?
|
Vascular Surgical Procedures | 8 | 2023 | 1506 | 1.210 |
Why?
|
Anticoagulants | 12 | 2024 | 4854 | 1.180 |
Why?
|
Aged | 101 | 2025 | 171446 | 1.110 |
Why?
|
Humans | 234 | 2025 | 767991 | 1.080 |
Why?
|
Product Surveillance, Postmarketing | 3 | 2024 | 463 | 1.010 |
Why?
|
Hospital Mortality | 20 | 2024 | 5349 | 1.000 |
Why?
|
Postoperative Hemorrhage | 3 | 2021 | 419 | 0.990 |
Why?
|
Hemorrhage | 18 | 2024 | 3467 | 0.960 |
Why?
|
Retrospective Studies | 60 | 2025 | 81746 | 0.920 |
Why?
|
Healthcare Disparities | 9 | 2025 | 3414 | 0.900 |
Why?
|
Hypertension, Renovascular | 1 | 2024 | 115 | 0.890 |
Why?
|
Coronary Thrombosis | 6 | 2018 | 440 | 0.880 |
Why?
|
Coronary Occlusion | 4 | 2022 | 306 | 0.870 |
Why?
|
Pharmaceutical Preparations | 3 | 2022 | 1086 | 0.860 |
Why?
|
Time Factors | 48 | 2025 | 40214 | 0.850 |
Why?
|
Thrombolytic Therapy | 11 | 2024 | 2055 | 0.820 |
Why?
|
Atherectomy | 4 | 2023 | 42 | 0.820 |
Why?
|
United States Social Security Administration | 1 | 2022 | 10 | 0.810 |
Why?
|
Stroke | 18 | 2024 | 9755 | 0.810 |
Why?
|
Pacemaker, Artificial | 3 | 2023 | 828 | 0.800 |
Why?
|
Thrombectomy | 4 | 2024 | 676 | 0.800 |
Why?
|
Elephants | 1 | 2022 | 41 | 0.770 |
Why?
|
Device Removal | 2 | 2024 | 643 | 0.770 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2024 | 1250 | 0.760 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2024 | 291 | 0.740 |
Why?
|
Peptide Fragments | 5 | 2020 | 5151 | 0.740 |
Why?
|
Shock, Cardiogenic | 5 | 2023 | 711 | 0.740 |
Why?
|
Vascular Diseases | 3 | 2024 | 1162 | 0.730 |
Why?
|
Angiography | 3 | 2024 | 1597 | 0.730 |
Why?
|
Risk Assessment | 36 | 2025 | 24314 | 0.730 |
Why?
|
Male | 108 | 2025 | 364641 | 0.710 |
Why?
|
Hyperpigmentation | 5 | 2021 | 116 | 0.700 |
Why?
|
Hirudins | 3 | 2017 | 179 | 0.690 |
Why?
|
Heart Diseases | 2 | 2023 | 2819 | 0.690 |
Why?
|
Exercise Therapy | 2 | 2024 | 939 | 0.680 |
Why?
|
Female | 113 | 2025 | 397113 | 0.670 |
Why?
|
Venous Thromboembolism | 5 | 2021 | 1883 | 0.670 |
Why?
|
Patient Discharge | 9 | 2024 | 3476 | 0.670 |
Why?
|
Renal Dialysis | 2 | 2024 | 1791 | 0.670 |
Why?
|
Angioplasty | 2 | 2019 | 355 | 0.660 |
Why?
|
HIV Infections | 12 | 2023 | 17569 | 0.660 |
Why?
|
Acute Disease | 11 | 2024 | 7241 | 0.650 |
Why?
|
Databases, Factual | 9 | 2024 | 8082 | 0.640 |
Why?
|
Sympathectomy | 3 | 2024 | 72 | 0.640 |
Why?
|
Fibrinolytic Agents | 6 | 2024 | 2080 | 0.630 |
Why?
|
Coronary Angiography | 11 | 2024 | 4541 | 0.620 |
Why?
|
Defibrillators, Implantable | 3 | 2023 | 1499 | 0.620 |
Why?
|
Aged, 80 and over | 34 | 2025 | 59598 | 0.620 |
Why?
|
Aspirin | 5 | 2024 | 3135 | 0.600 |
Why?
|
Consensus | 7 | 2024 | 3210 | 0.600 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 879 | 0.590 |
Why?
|
Aorta, Thoracic | 1 | 2024 | 1110 | 0.580 |
Why?
|
Middle Aged | 68 | 2024 | 223422 | 0.570 |
Why?
|
Angina Pectoris | 3 | 2022 | 957 | 0.570 |
Why?
|
Antithrombins | 2 | 2017 | 294 | 0.560 |
Why?
|
Cooperative Behavior | 1 | 2024 | 1512 | 0.560 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 163 | 0.550 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5182 | 0.550 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2496 | 0.540 |
Why?
|
Heart Rate | 3 | 2015 | 4215 | 0.540 |
Why?
|
Ticlopidine | 3 | 2019 | 730 | 0.530 |
Why?
|
Mortality | 4 | 2021 | 2910 | 0.510 |
Why?
|
Patient Care Team | 2 | 2024 | 2521 | 0.500 |
Why?
|
Coronary Stenosis | 1 | 2021 | 802 | 0.480 |
Why?
|
Patient Selection | 3 | 2024 | 4258 | 0.470 |
Why?
|
Heart Failure, Diastolic | 1 | 2015 | 77 | 0.470 |
Why?
|
Inpatients | 5 | 2024 | 2570 | 0.460 |
Why?
|
Pneumonia | 2 | 2023 | 2163 | 0.450 |
Why?
|
Hypertension | 5 | 2024 | 8616 | 0.440 |
Why?
|
Myocardial Revascularization | 1 | 2017 | 795 | 0.440 |
Why?
|
Heart Failure | 7 | 2024 | 11883 | 0.430 |
Why?
|
Propensity Score | 4 | 2021 | 1970 | 0.430 |
Why?
|
Hospitalization | 11 | 2024 | 10840 | 0.430 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 642 | 0.430 |
Why?
|
Brain Ischemia | 2 | 2017 | 3007 | 0.410 |
Why?
|
Embolic Protection Devices | 2 | 2024 | 43 | 0.410 |
Why?
|
Heparin | 2 | 2017 | 1636 | 0.410 |
Why?
|
Incidence | 15 | 2024 | 21532 | 0.410 |
Why?
|
Raynaud Disease | 2 | 2024 | 81 | 0.400 |
Why?
|
Cardiology | 7 | 2024 | 1702 | 0.400 |
Why?
|
Health Status Disparities | 2 | 2020 | 1885 | 0.390 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 538 | 0.380 |
Why?
|
Drug Therapy, Combination | 9 | 2023 | 6314 | 0.380 |
Why?
|
Antineoplastic Agents, Phytogenic | 5 | 2021 | 617 | 0.370 |
Why?
|
Prospective Studies | 21 | 2024 | 54924 | 0.370 |
Why?
|
Embolectomy | 2 | 2023 | 130 | 0.360 |
Why?
|
American Heart Association | 3 | 2024 | 1050 | 0.350 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1551 | 0.350 |
Why?
|
Quality of Life | 9 | 2023 | 13489 | 0.350 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1605 | 0.340 |
Why?
|
Sunscreening Agents | 3 | 2019 | 139 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2298 | 0.340 |
Why?
|
Electrocardiography | 2 | 2015 | 6411 | 0.340 |
Why?
|
Radial Artery | 2 | 2024 | 188 | 0.330 |
Why?
|
Ischemic Attack, Transient | 1 | 2015 | 877 | 0.320 |
Why?
|
Vasoconstrictor Agents | 2 | 2019 | 656 | 0.320 |
Why?
|
Death, Sudden, Cardiac | 3 | 2014 | 1567 | 0.320 |
Why?
|
Arteries | 3 | 2023 | 1127 | 0.320 |
Why?
|
Beauty | 2 | 2020 | 41 | 0.320 |
Why?
|
Choice Behavior | 3 | 2024 | 848 | 0.310 |
Why?
|
Pyridines | 2 | 2017 | 2893 | 0.300 |
Why?
|
Sunburn | 2 | 2019 | 156 | 0.300 |
Why?
|
Odds Ratio | 7 | 2022 | 9666 | 0.290 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1751 | 0.290 |
Why?
|
Sirolimus | 3 | 2022 | 1538 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2024 | 10396 | 0.280 |
Why?
|
Postoperative Complications | 5 | 2024 | 15831 | 0.270 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15442 | 0.270 |
Why?
|
Chronic Disease | 11 | 2024 | 9384 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2138 | 0.270 |
Why?
|
Blood Pressure | 3 | 2024 | 8540 | 0.270 |
Why?
|
Cocaine | 1 | 2011 | 947 | 0.260 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5887 | 0.260 |
Why?
|
Antihypertensive Agents | 3 | 2024 | 2029 | 0.260 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2819 | 0.260 |
Why?
|
Renal Artery | 2 | 2024 | 354 | 0.250 |
Why?
|
Skin Pigmentation | 2 | 2018 | 280 | 0.250 |
Why?
|
Aortic Valve Stenosis | 3 | 2024 | 2032 | 0.250 |
Why?
|
Autonomic Nervous System | 1 | 2010 | 707 | 0.250 |
Why?
|
Prosthesis Design | 3 | 2023 | 2125 | 0.250 |
Why?
|
Heart Conduction System | 1 | 2010 | 1009 | 0.240 |
Why?
|
Comorbidity | 5 | 2024 | 10590 | 0.240 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1724 | 0.240 |
Why?
|
Patient Transfer | 1 | 2011 | 790 | 0.230 |
Why?
|
Iliac Vein | 1 | 2024 | 71 | 0.230 |
Why?
|
Arrhythmias, Cardiac | 2 | 2011 | 2258 | 0.230 |
Why?
|
Death, Sudden | 2 | 2018 | 301 | 0.230 |
Why?
|
Asymptomatic Diseases | 2 | 2024 | 590 | 0.220 |
Why?
|
Delphi Technique | 2 | 2024 | 891 | 0.220 |
Why?
|
Venous Insufficiency | 1 | 2024 | 109 | 0.210 |
Why?
|
Insurance Benefits | 1 | 2024 | 185 | 0.210 |
Why?
|
Aftercare | 3 | 2023 | 916 | 0.200 |
Why?
|
Cohort Studies | 11 | 2024 | 41749 | 0.200 |
Why?
|
Device Approval | 1 | 2024 | 164 | 0.200 |
Why?
|
Ultrasonography | 4 | 2024 | 6004 | 0.200 |
Why?
|
Heart-Assist Devices | 2 | 2023 | 1292 | 0.200 |
Why?
|
HIV | 2 | 2023 | 1597 | 0.200 |
Why?
|
Tubulin Modulators | 2 | 2020 | 106 | 0.200 |
Why?
|
Vascular System Injuries | 2 | 2023 | 248 | 0.200 |
Why?
|
Germany | 1 | 2024 | 883 | 0.190 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12536 | 0.190 |
Why?
|
International Classification of Diseases | 2 | 2024 | 936 | 0.190 |
Why?
|
Skin Diseases | 2 | 2022 | 1084 | 0.190 |
Why?
|
Shock | 1 | 2023 | 316 | 0.190 |
Why?
|
Aorta, Abdominal | 1 | 2024 | 627 | 0.190 |
Why?
|
Comprehension | 2 | 2024 | 639 | 0.180 |
Why?
|
Punctures | 2 | 2020 | 372 | 0.180 |
Why?
|
Sex Factors | 5 | 2021 | 10627 | 0.180 |
Why?
|
Adult | 30 | 2024 | 223583 | 0.180 |
Why?
|
Catheterization, Peripheral | 1 | 2024 | 347 | 0.180 |
Why?
|
Pulmonary Edema | 1 | 2023 | 408 | 0.170 |
Why?
|
Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
Europe | 2 | 2024 | 3437 | 0.170 |
Why?
|
Equipment Design | 4 | 2024 | 3522 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 4 | 2021 | 6517 | 0.170 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 713 | 0.170 |
Why?
|
Specialization | 1 | 2024 | 779 | 0.160 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2020 | 117 | 0.160 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 87 | 0.160 |
Why?
|
Myocardial Reperfusion | 1 | 2020 | 339 | 0.160 |
Why?
|
Kidney | 3 | 2024 | 7065 | 0.160 |
Why?
|
Esthetics | 2 | 2018 | 328 | 0.160 |
Why?
|
Peripheral Vascular Diseases | 1 | 2022 | 488 | 0.160 |
Why?
|
Veterans Health | 1 | 2021 | 216 | 0.160 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1126 | 0.160 |
Why?
|
Length of Stay | 5 | 2020 | 6495 | 0.160 |
Why?
|
Recombinant Proteins | 3 | 2017 | 6515 | 0.160 |
Why?
|
Interdisciplinary Communication | 1 | 2024 | 937 | 0.150 |
Why?
|
Protective Devices | 1 | 2018 | 72 | 0.150 |
Why?
|
Social Class | 3 | 2024 | 2007 | 0.150 |
Why?
|
Chemexfoliation | 1 | 2018 | 11 | 0.150 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2336 | 0.150 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15660 | 0.150 |
Why?
|
Lung Injury | 1 | 2023 | 433 | 0.150 |
Why?
|
Outpatients | 3 | 2024 | 1600 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 242 | 0.150 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 436 | 0.150 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39345 | 0.150 |
Why?
|
Veterans | 2 | 2023 | 2669 | 0.150 |
Why?
|
Aerospace Medicine | 1 | 2018 | 95 | 0.150 |
Why?
|
Constriction, Pathologic | 4 | 2023 | 1104 | 0.150 |
Why?
|
Habits | 1 | 2018 | 148 | 0.150 |
Why?
|
Environment, Controlled | 1 | 2017 | 42 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 956 | 0.150 |
Why?
|
Dermatology | 2 | 2018 | 905 | 0.150 |
Why?
|
Quality Improvement | 3 | 2022 | 3855 | 0.140 |
Why?
|
Survival Rate | 5 | 2020 | 12828 | 0.140 |
Why?
|
Chemoprevention | 1 | 2020 | 327 | 0.140 |
Why?
|
Learning Curve | 1 | 2019 | 232 | 0.140 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 285 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20218 | 0.140 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1395 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2019 | 246 | 0.140 |
Why?
|
Patient Preference | 1 | 2024 | 946 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 609 | 0.140 |
Why?
|
Sunlight | 1 | 2018 | 337 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 4055 | 0.130 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2021 | 519 | 0.130 |
Why?
|
Absorbable Implants | 1 | 2019 | 337 | 0.130 |
Why?
|
Color Perception | 1 | 2017 | 212 | 0.130 |
Why?
|
Erythema | 1 | 2018 | 261 | 0.130 |
Why?
|
Lasers | 1 | 2020 | 952 | 0.130 |
Why?
|
Prognosis | 6 | 2023 | 29979 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 1 | 2020 | 744 | 0.130 |
Why?
|
Sickness Impact Profile | 1 | 2017 | 299 | 0.130 |
Why?
|
Communication Barriers | 1 | 2019 | 419 | 0.130 |
Why?
|
Hospital Costs | 2 | 2019 | 957 | 0.130 |
Why?
|
Brachial Artery | 1 | 2017 | 373 | 0.130 |
Why?
|
Health Care Costs | 3 | 2024 | 3239 | 0.130 |
Why?
|
Conscious Sedation | 1 | 2020 | 534 | 0.130 |
Why?
|
Cause of Death | 4 | 2023 | 3720 | 0.120 |
Why?
|
Health Status | 3 | 2024 | 4092 | 0.120 |
Why?
|
Drug Utilization Review | 1 | 2016 | 248 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1207 | 0.120 |
Why?
|
Reminder Systems | 1 | 2018 | 388 | 0.120 |
Why?
|
Malnutrition | 1 | 2022 | 632 | 0.120 |
Why?
|
Hemostatic Techniques | 1 | 2016 | 116 | 0.120 |
Why?
|
Coronary Vessels | 4 | 2022 | 3124 | 0.120 |
Why?
|
Body Image | 1 | 2020 | 646 | 0.120 |
Why?
|
Seasons | 2 | 2018 | 1524 | 0.120 |
Why?
|
Object Attachment | 1 | 2017 | 326 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 893 | 0.120 |
Why?
|
Ankle | 1 | 2017 | 353 | 0.120 |
Why?
|
Risk Adjustment | 1 | 2018 | 599 | 0.110 |
Why?
|
Walking | 1 | 2021 | 1201 | 0.110 |
Why?
|
Drug Utilization | 1 | 2020 | 1190 | 0.110 |
Why?
|
Metals | 1 | 2018 | 713 | 0.110 |
Why?
|
Research Design | 2 | 2021 | 6211 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2024 | 5366 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 904 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 870 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2020 | 1474 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26375 | 0.110 |
Why?
|
Cost-Benefit Analysis | 2 | 2024 | 5536 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15944 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2020 | 1189 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4857 | 0.100 |
Why?
|
Natriuretic Peptides | 1 | 2014 | 156 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1798 | 0.100 |
Why?
|
Social Responsibility | 1 | 2015 | 382 | 0.100 |
Why?
|
Logistic Models | 4 | 2024 | 13289 | 0.100 |
Why?
|
Polymers | 1 | 2019 | 1627 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1101 | 0.090 |
Why?
|
Light | 1 | 2017 | 1358 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 714 | 0.090 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2708 | 0.090 |
Why?
|
Affect | 1 | 2019 | 1495 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 819 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1257 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1566 | 0.090 |
Why?
|
Drug Costs | 1 | 2019 | 1195 | 0.090 |
Why?
|
Freedom | 2 | 2021 | 69 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1480 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4030 | 0.090 |
Why?
|
HIV Protease Inhibitors | 1 | 2012 | 430 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3342 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5861 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7445 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 252 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5794 | 0.080 |
Why?
|
Disclosure | 1 | 2015 | 755 | 0.080 |
Why?
|
Double-Blind Method | 3 | 2018 | 12464 | 0.080 |
Why?
|
Echocardiography | 3 | 2020 | 5050 | 0.080 |
Why?
|
Algorithms | 3 | 2024 | 14163 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3886 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2191 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2808 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1483 | 0.080 |
Why?
|
Thoracic Surgery | 1 | 2015 | 727 | 0.080 |
Why?
|
Recurrence | 1 | 2021 | 8507 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1942 | 0.080 |
Why?
|
Skin | 2 | 2022 | 4503 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1805 | 0.080 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 2194 | 0.080 |
Why?
|
Mass Screening | 1 | 2024 | 5458 | 0.070 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.070 |
Why?
|
Reference Values | 1 | 2015 | 4938 | 0.070 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2010 | 582 | 0.070 |
Why?
|
Health Expenditures | 1 | 2020 | 2389 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2019 | 1946 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3619 | 0.070 |
Why?
|
United States Department of Veterans Affairs | 2 | 2023 | 937 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3231 | 0.070 |
Why?
|
Mitral Valve | 1 | 2015 | 1475 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2517 | 0.070 |
Why?
|
Pyrazoles | 1 | 2016 | 2028 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2515 | 0.060 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.060 |
Why?
|
Smoking | 2 | 2020 | 9089 | 0.060 |
Why?
|
New York | 2 | 2019 | 882 | 0.060 |
Why?
|
Medicaid | 1 | 2019 | 2840 | 0.060 |
Why?
|
Aortic Diseases | 1 | 2011 | 741 | 0.060 |
Why?
|
RNA, Viral | 1 | 2014 | 2871 | 0.060 |
Why?
|
Age Factors | 5 | 2021 | 18407 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3251 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2175 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14783 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4713 | 0.060 |
Why?
|
Viral Load | 1 | 2014 | 3396 | 0.060 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 810 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7939 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 89155 | 0.060 |
Why?
|
Postpartum Period | 2 | 2021 | 1198 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1793 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4857 | 0.050 |
Why?
|
Weight Gain | 1 | 2014 | 2359 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2014 | 2145 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6983 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2024 | 188 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3463 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4205 | 0.050 |
Why?
|
Dinucleoside Phosphates | 1 | 2022 | 70 | 0.050 |
Why?
|
Hemoptysis | 1 | 2023 | 152 | 0.050 |
Why?
|
Hydroquinones | 1 | 2021 | 34 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
Nitroglycerin | 1 | 2022 | 332 | 0.050 |
Why?
|
Catheter Ablation | 2 | 2024 | 2787 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2025 | 7851 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 60048 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16723 | 0.040 |
Why?
|
New Zealand | 1 | 2020 | 360 | 0.040 |
Why?
|
Disease Management | 2 | 2021 | 2533 | 0.040 |
Why?
|
Premedication | 1 | 2020 | 245 | 0.040 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2957 | 0.040 |
Why?
|
Accidents, Aviation | 1 | 2018 | 15 | 0.040 |
Why?
|
Depression | 1 | 2019 | 8231 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 299 | 0.040 |
Why?
|
Edema | 1 | 2023 | 765 | 0.040 |
Why?
|
Wit and Humor as Topic | 1 | 2018 | 31 | 0.040 |
Why?
|
Prevalence | 2 | 2019 | 15867 | 0.040 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.040 |
Why?
|
Health Literacy | 1 | 2024 | 466 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2020 | 520 | 0.040 |
Why?
|
Body Fat Distribution | 1 | 2020 | 246 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 330 | 0.040 |
Why?
|
Data Collection | 2 | 2019 | 3326 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2021 | 2008 | 0.040 |
Why?
|
Sunbathing | 1 | 2018 | 66 | 0.040 |
Why?
|
Aircraft | 1 | 2018 | 135 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.040 |
Why?
|
Florida | 1 | 2019 | 417 | 0.040 |
Why?
|
Veins | 1 | 2022 | 769 | 0.040 |
Why?
|
Hematoma | 1 | 2022 | 766 | 0.040 |
Why?
|
Facial Dermatoses | 1 | 2018 | 87 | 0.040 |
Why?
|
Mental Health | 2 | 2024 | 3275 | 0.030 |
Why?
|
Skin Aging | 1 | 2018 | 140 | 0.030 |
Why?
|
Critical Illness | 2 | 2020 | 2756 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1835 | 0.030 |
Why?
|
Medication Therapy Management | 1 | 2018 | 131 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1265 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 220 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1363 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1217 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2129 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1382 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1671 | 0.030 |
Why?
|
Markov Chains | 1 | 2019 | 979 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 2018 | 463 | 0.030 |
Why?
|
Photography | 1 | 2018 | 537 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 575 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 812 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1049 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1008 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 719 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2025 | 2118 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 646 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1088 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1946 | 0.030 |
Why?
|
India | 1 | 2020 | 2334 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13665 | 0.030 |
Why?
|
San Francisco | 1 | 2014 | 166 | 0.030 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 550 | 0.030 |
Why?
|
Workload | 1 | 2019 | 849 | 0.030 |
Why?
|
California | 1 | 2017 | 1438 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5314 | 0.030 |
Why?
|
Troponin T | 1 | 2018 | 787 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2358 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1299 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2515 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1484 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1741 | 0.020 |
Why?
|
Life Style | 1 | 2024 | 3932 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2276 | 0.020 |
Why?
|
Morbidity | 1 | 2017 | 1754 | 0.020 |
Why?
|
Societies, Medical | 1 | 2024 | 3966 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2227 | 0.020 |
Why?
|
Aortic Valve | 1 | 2021 | 1970 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3435 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2506 | 0.020 |
Why?
|
Animals | 1 | 2022 | 169222 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3904 | 0.020 |
Why?
|
Heart Arrest | 1 | 2019 | 1516 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 2 | 2015 | 3683 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30260 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1572 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10098 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10757 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2726 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3841 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3532 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9368 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2025 | 5520 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2766 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2650 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2913 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1465 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3858 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5884 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3110 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4884 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8052 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4310 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12075 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8748 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42665 | 0.010 |
Why?
|
Stroke Volume | 1 | 2014 | 5624 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18062 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20757 | 0.010 |
Why?
|